Product Information
AMLODIPINE-BENAZEPRIL 10-40 MG is a generic product labeled by Heritage Pharmaceuticals Inc., priced at $0.1522 per EA under NDC 23155092501. Its NADAC has been published 35 times since Feb 4, 2026.
FDA first approved this application on Dec 30, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 40 mg/1; mg/1
Manufacturer
Heritage Pharmaceuticals Inc.NDC
23155092501
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA091431FDA Approved
12/30/2013
TE Code
AB
On Market Since
10/15/2025
Pharmacological Classes
Price Statistics
The NADAC for AMLODIPINE-BENAZEPRIL 10-40 MG has been published 35 times since Feb 4, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1522 per EA |
|---|---|
| All-time high | $0.1578 (Apr 15, 2026) |
| All-time low | $0.1508 (Jul 22, 2026) |
| 52-week high | $0.1578 |
| 52-week low | $0.1508 |
| Median price | $0.1536 |
| Average price | $0.1540 |
| Largest weekly change | -2.9% (May 20, 2026) |
| Weeks tracked | 35 |
| Tracking since | Feb 4, 2026 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Heritage Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Amlodipine and Benazepril Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin Converting Enzyme Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of AMLODIPINE-BENAZEPRIL 10-40 MG?
The current National Average Drug Acquisition Cost (NADAC) for AMLODIPINE-BENAZEPRIL 10-40 MG, manufactured by Heritage Pharmaceuticals Inc., is $0.1522 per EA (NDC 23155092501), effective Sep 30, 2026.
How has the price of AMLODIPINE-BENAZEPRIL 10-40 MG changed over time?
Over the history we have for it, the NADAC for AMLODIPINE-BENAZEPRIL 10-40 MG has held within roughly two percent of its current level. It has been tracked across 35 weekly CMS publications since Feb 4, 2026.
What are the highest and lowest recorded NADAC prices for AMLODIPINE-BENAZEPRIL 10-40 MG?
Since Feb 4, 2026, the NADAC for AMLODIPINE-BENAZEPRIL 10-40 MG has ranged from a low of $0.1508 (Jul 22, 2026) to a high of $0.1578 (Apr 15, 2026), with a median of $0.1536 per EA.
Are there cheaper alternatives to AMLODIPINE-BENAZEPRIL 10-40 MG?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMLODIPINE-BENAZEPRIL 10-40 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures AMLODIPINE-BENAZEPRIL 10-40 MG?
AMLODIPINE-BENAZEPRIL 10-40 MG (NDC 23155092501) is labeled by Heritage Pharmaceuticals Inc., and CMS classifies it as a generic product.